• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS MESH SOFRADIM - PARIETEX¿ OPTIMIZED COMPOSITE MESH; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOFRADIM PRODUCTION SAS MESH SOFRADIM - PARIETEX¿ OPTIMIZED COMPOSITE MESH; MESH, SURGICAL, POLYMERIC Back to Search Results
Model Number PCO1510OSX
Device Problems Material Integrity Problem (2978); Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Adhesion(s) (1695); Anemia (1706); Cyst(s) (1800); Dyspnea (1816); Emotional Changes (1831); Hemorrhage/Bleeding (1888); Failure of Implant (1924); Pain (1994); Hernia (2240); Injury (2348); Blood Loss (2597); No Code Available (3191); Nodule (4551); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device resulting in an unspecified adverse outcome.Product was used for therapeutic treatment.The patient underwent a repair of recurrent incisional hernia with mesh.She had revision surgery 1 year and 4 months post-surgery.The patient experienced chronic pain, mesh contraction/failure and revision.
 
Manufacturer Narrative
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device.Product was used for therapeutic treatment of a recurrent incisional hernia with mesh.It was reported that after the implant, the patient experienced chronic pain, mesh contraction/failure, recurrence, mild diverticulosis, cyst, esophagitis, shortness of breath, bleeding, anemia, small tear in spleen, and adhesions.Post-operative patient treatment included revision surgery, repair of hernia, lysis of adhesions, repair of small tear in spleen, and excision of mesh.
 
Manufacturer Narrative
This information was received as a part of an extensive mesh litigation submission to medtronic.The fda was notified of this large complaint receipt.Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device resulting in an unspecified adverse outcome.Product was used for therapeutic treatment of a recurrent incisional hernia with mesh.It was reported that after the implant, the patient experienced chronic pain, mesh contraction/failure, recurrence, and adhesions.Post-operative patient treatment included revision surgery and excision of mesh.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device.Product was used for therapeutic treatment of a recurrent incisional hernia with mesh.It was reported that after the implant, the patient experienced defective device, mental pain, disability, impairment, loss of enjoyment of life, chronic pain, mesh contraction/failure, recurrence, mild diverticulosis, cyst, esophagitis, shortness of breath, bleeding, anemia, small tear in spleen, and adhesions.Post-operative patient treatment included revision surgery, repair of hernia, lysis of adhesions, repair of small tear in spleen, hernia repair with mesh, and excision of mesh.
 
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient's attorney alleged a deficiency against the device.Product was used for therapeutic treatment of a recurrent incisional hernia with mesh.It was reported that after the implant, the patient experienced defective device, mental pain, disability, impairment, loss of enjoyment of life, chronic pain, mesh contraction/failure, recurrence, mild diverticulosis, cyst, esophagitis, shortness of breath, bleeding, anemia, small tear in spleen, lump in stomach, and adhesions.Post-operative patient treatment included revision surgery, repair of hernia, lysis of adhesions, repair of small tear in spleen, hernia repair with mesh, ct-scan, primary care, and excision of mesh.Relevant tests/laboratory data 02 jun 2016- ct scan demonstrated 2 new hernias of the upper abdominal wall containing fat, as well as a large hiatal hernia, mild diverticulosis, right diaphragmatic hernia, and left adnexal cyst.Egd noted hiatal hernia with associated esophagitis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MESH SOFRADIM - PARIETEX¿ OPTIMIZED COMPOSITE MESH
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR  01600
Manufacturer (Section G)
SOFRADIM PRODUCTION SAS
116 avenue du formans
trevoux 01600
FR   01600
Manufacturer Contact
justin ellis
5920 longbow dr
8200 coral sea st ne
mounds view,mn, CO 55112
7635265677
MDR Report Key7034968
MDR Text Key92116159
Report Number9615742-2017-05759
Device Sequence Number1
Product Code FTL
UDI-Device Identifier10884521179691
UDI-Public10884521179691
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K110816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 08/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/15/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2019
Device Model NumberPCO1510OSX
Device Catalogue NumberPCO1510OSX
Device Lot NumberPOB0573X
Was Device Available for Evaluation? No
Date Manufacturer Received08/23/2023
Date Device Manufactured03/06/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
UNKNOWN PROTACK (LOT#: UNKNOWN).
Patient Outcome(s) Required Intervention; Other; Disability;
Patient SexFemale
Patient Weight68 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-